End-of-Treatment-Response in patients treated for hepatitis C virus with standard interferon and ribavirin based on viral load.

doi:02.2015/JCPSP.104107

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

End-of-Treatment-Response in patients treated for hepatitis C virus with standard interferon and ribavirin based on viral load.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP - 1 Feb 2015

Rathore Muhammad Ali, Hussain Agha Babar, Ghani Eijaz

Abstract excerpt

OBJECTIVE: To determine the End-of-Treatment-Response (ETR) to standard interferon and ribavirin based regimen in patients of chronic hepatitis C and to compare the ETR response in low and high viral load groups. STUDY DESIGN: Descriptive study. PLACE AND DURATION OF STUDY: Virology Department, Armed Forces Institute of Pathology (AFIP), Rawalpindi, from March 2012 to May 2013. METHODOLOGY: Patients with chronic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination
Share to Hepacivirus
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Ribavirin

Share to RNA, Viral

Share to Viral Load

Source

Open in PubMed

Identifiers

PMID: 25703752
DOI: 02.2015/JCPSP.104107

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.